Drug · DIN 02479540
RIVASTIGMINE PATCH 5
Authorized, but not sold for a year or more
Authorized, but the company reports it has not been sold in Canada for at least 12 months.
Status Dormant since July 31, 2024; first marketed April 15, 2021.
- Drug Identification Number (DIN)
- 02479540
- Company (DIN owner)
- Pharmascience Inc.Montreal, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Patch
- Route
- Transdermal
- Therapeutic class (ATC)
- Rivastigmine N06DA03
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RIVASTIGMINE | 4.6 MG | 24 HOUR |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 7, 2023: NOC 32045Abbreviated New Drug Submission (ANDS) · Administrative: Change in Product Ownership
- January 28, 2021: NOC 25097Supplement to an Abbreviated New Drug Submission (SANDS) · Product name change. updating the product monograph and package insert
- March 18, 2019: NOC 21981Abbreviated New Drug Submission (ANDS) · Change in product ownership
- July 30, 2018: NOC 21157Abbreviated New Drug Submission (ANDS)